Foresite Capital Management I, LLC

Q2 2014 13F-HR Holdings

Location
San Francisco, CA
Holdings as of
6/30/2014
Date filed
8/11/2014
Form type
13F-HR
Num holdings
8
Total value ($000)
$119,290
Net value change ($000)
-23,062 (-16.2%)
New positions
0
Sold out positions
2
Turnover %
23.8%
Sector allocation + QoQ delta (equities-only)

Snapshot: Change Analysis

Compared to Q1 2014
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
KPTI 15,134 30.9%
BIODELIVERY SCIENCES INTERNATIONAL INC 2,541 43.0%
XLRN 1,173 162.7%
IGNYTA INC 395 9.5%
Top Reduces (Value $000, Stocks/ETFs)
KERYX BIOPHARMACEUTICALS -22,357 -100.0%
TLPH -7,871 -47.5%
NVAX -6,053 -100.0%
AMBIT BIOSCIENCES CORP -4,596 -24.2%
OREXIGEN THERAPEUTICS INC -400 -4.9%
XNCR -122 -1.3%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type